Quick filters:
Open Data
Open Code
Pre-registered
Funding Declared
COI Declared
Open Access
Clear Filters
A phase 2, multicenter, open-label study of anti-LAG-3 ieramilimab in combination with anti-PD-1 spartalizumab in patie…
Lin CC; Garralda E; Schöffski P; Hong DS; Siu LL; Martin M; Maur M; Hui R; Soo RA; Chiu J; Zhang T; Ma B; Kyi C; Tan DS; Cassier PA; Sarantopoulos J; Weickhardt A; Carvajal RD; Spratlin J; Esaki T; Rolland F; Akerley W; Deschler-Baier B; Rispoli L; Samant TS; Chowdhury NR; Gusenleitner D; Kwak EL; Askoxylakis V; De Braud F.
Oncoimmunology
(Unknown)
Published: 2023
Unbiased high-dimensional flow cytometry identified NK and DC immune cell signature in Luminal A-type and triple negati…
Heger L; Heidkamp GF; Amon L; Nimmerjahn F; Bäuerle T; Maier A; Erber R; Hartmann A; Hack CC; Ruebner M; Huebner H; Fasching P; Beckmann MW; Dudziak D.
Oncoimmunology
(Unknown)
Published: 2023
Activation of endogenous glucocorticoids by HSD11B1 inhibits the antitumor immune response in renal cancer.
Poinot H; Dupuychaffray E; Arnoux G; Alvarez M; Tachet J; Ezzar O; Moore J; Bejuy O; Olesti E; Visconti G; González-Ruiz V; Rudaz S; Tille JC; Voegel CD; Nowak-Sliwinska P; Bourquin C; Pommier A.
Oncoimmunology
(Unknown)
Published: 2023
Cell type-specific induction of ferroptosis to boost antitumor immunity.
Oncoimmunology
(Unknown)
Published: 2023
Safety and effectiveness of combination versus monotherapy with immune checkpoint inhibitors in patients with preexisti…
Reid P; Sandigursky S; Song J; Lopez-Olivo MA; Safa H; Cytryn S; Efuni E; Buni M; Pavlick A; Krogsgaard M; Abu-Shawer O; Altan M; Weber JS; Rahma OE; Suarez-Almazor ME; Diab A; Abdel-Wahab N.
Oncoimmunology
(Unknown)
Published: 2023
Whole stromal fibroblast signature is linked to specific chemokine and immune infiltration patterns and to improved sur…
Koeck S; Amann A; Kern J; Zwierzina M; Lorenz E; Sopper S; Zwierzina H; Mildner F; Sykora M; Sprung S; Hackl H; Augustin F; Maier HT; Pircher A; Pall G; Wolf D; Gamerith G.
Oncoimmunology
(Unknown)
Published: 2023
LTX-315 and adoptive cell therapy using tumor-infiltrating lymphocytes generate tumor specific T cells in patients with…
Nielsen M; Monberg T; Sundvold V; Albieri B; Hovgaard D; Petersen MM; Krarup-Hansen A; Met Ö; Met Ö; Camilio K; Clancy T; Stratford R; Sveinbjornsson B; Rekdal Ø; Junker N; Svane IM.
Oncoimmunology
(Unknown)
Published: 2023
Emergence of immune-related adverse events correlates with pathological complete response in patients receiving pembrol…
Marhold M; Udovica S; Halstead A; Hirdler M; Ferner M; Wimmer K; Bago-Horvath Z; Exner R; Fitzal F; Strasser-Weippl K; Robinson T; Bartsch R.
Oncoimmunology
(Unknown)
Published: 2023
<i>PD-L1</i> (<i>CD274</i>) promoter hypomethylation predicts immunotherapy response in metastatic urothelial carcinoma.
Klümper N; Wüst L; Saal J; Ralser DJ; Zarbl R; Jarczyk J; Breyer J; Sikic D; Wullich B; Bolenz C; Roghmann F; Hölzel M; Ritter M; Strieth S; Hartmann A; Erben P; Wirtz RM; Landsberg J; Dietrich D; Eckstein M.
Oncoimmunology
(Unknown)
Published: 2023
A mitochondrial checkpoint to adaptive anticancer immunity.
Oncoimmunology
(Unknown)
Published: 2023
Non-pharmaceutical interventions to optimize cancer immunotherapy.
Oncoimmunology
(Unknown)
Published: 2023
Immune checkpoint blockade therapy mitigates systemic inflammation and affects cellular FLIP-expressing monocytic myelo…
Adamo A; Frusteri C; Pilotto S; Caligola S; Belluomini L; Poffe O; Giacobazzi L; Dusi S; Musiu C; Hu Y; Wang T; Rizzini D; Vella A; Canè S; Sartori G; Insolda J; Sposito M; Incani UC; Carbone C; Piro G; Pettinella F; Qi F; Wang D; Sartoris S; De Sanctis F; Scapini P; Dusi S; Cassatella MA; Bria E; Milella M; Bronte V; Ugel S.
Oncoimmunology
(Unknown)
Published: 2023